U.S. Urticaria Market & Competitive Landscape 2014-2024 - ResearchAndMarkets.com

DUBLIN--()--The "US Urticaria Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.

US Urticaria Market and Competitive Landscape Highlights - 2019, provides comprehensive insights into Urticaria pipeline products, Urticaria epidemiology, Urticaria market valuations and forecast, Urticaria drugs sales and competitive landscape in the US.

The research is classified into seven sections - Urticaria treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope

  • Urticaria pipeline: Find out the products in clinical trials for the treatment of Urticaria by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Urticaria epidemiology: Find out the number of patients diagnosed (prevalence) with Urticaria in the US
  • Urticaria drugs: Identify key products marketed and prescribed for Urticaria in the US, including trade name, molecule name, and company
  • Urticaria drugs sales: Find out the sales revenues of Urticaria drugs in the US
  • Urticaria market valuations: Find out the market size for Urticaria drugs in 2018 in the US. Find out how the market advanced from 2014 and forecast to 2024
  • Urticaria drugs market share: Find out the market shares for key Urticaria drugs in the US

Benefits of this Research

  • Support monitoring and reporting national Urticaria market analysis and sales trends
  • Track competitor drugs sales and market share in the US Urticaria market
  • Track competitive developments in Urticaria market and present key issues and learnings
  • Synthesize insights for Urticaria market and products to drive business performance
  • Answer key business questions about the Urticaria market
  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Urticaria products
  • Supports decision making in R&D to long term marketing strategies

Key Topics Covered

1) Urticaria Treatments

2) Urticaria Pipeline

3) US Urticaria Epidemiology

4) Marketed Drugs for Urticaria in US

5) US Urticaria Market Size and Forecast

6) US Urticaria Products Sales and Forecast

7) US Urticaria Market Competitive Landscape

8) Methodology

List of Tables

1. Urticaria Phase 3 Clinical Trials, 2019

2. Urticaria Phase 2 Clinical Trials, 2019

3. Urticaria Phase 1 Clinical Trials, 2019

4. Urticaria Epidemiology, US, 2014 - 2024

5. Marketed Drugs for Urticaria, US, 2018

6. Urticaria Market Size and Forecast ($), US, 2014 - 2024

7. Urticaria Product Sales ($), US, 2014 - 2024

List of Figures

1. Urticaria Epidemiology, US, 2014 - 2024

2. Urticaria Market Size and Forecast ($), US, 2014 - 2024

3. Urticaria Products Market Share (%), US, 2018

For more information about this report visit https://www.researchandmarkets.com/r/d50tnt

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Dermatological Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Dermatological Drugs